(Press-News.org) Johns Hopkins researchers say they have successfully used stem cells derived from human body fat to deliver biological treatments directly to the brains of mice with the most common and aggressive form of brain tumor, significantly extending their lives.
The experiments advance the possibility, the researchers say, that the technique could work in people after surgical removal of brain cancers called glioblastomas to find and destroy any remaining cancer cells in difficult-to-reach areas of the brain. Glioblastoma cells are particularly nimble; they are able to migrate across the entire brain, hide out and establish new tumors. Cure rates for the tumor are notoriously low as a result.
In the mouse experiments, the Johns Hopkins investigators used mesenchymal stem cells (MSCs) — which have an unexplained ability to seek out cancer and other damaged cells — that they harvested from human fat tissue. They modified the MSCs to secrete bone morphogenetic protein 4 (BMP4), a small protein involved in regulating embryonic development and known to have some tumor suppression function. The researchers, who had already given a group of mice glioblastoma cells several weeks earlier, injected stem cells armed with BMP4 into their brains.
In a report published in the May 1 issue of Clinical Cancer Research, the investigators say the mice treated this way had less tumor growth and spread, and their cancers were overall less aggressive and had fewer migratory cancer cells compared to mice that didn't get the treatment. Meanwhile, the mice that received stem cells with BMP4 survived significantly longer, living an average of 76 days, as compared to 52 days in the untreated mice.
"These modified mesenchymal stem cells are like a Trojan horse, in that they successfully make it to the tumor without being detected and then release their therapeutic contents to attack the cancer cells," says study leader Alfredo Quinones-Hinojosa, M.D., a professor of neurosurgery, oncology and neuroscience at the Johns Hopkins University School of Medicine.
Standard treatments for glioblastoma include chemotherapy, radiation and surgery, but even a combination of all three rarely leads to more than 18 months of survival after diagnosis. Finding a way to get biologic therapy to mop up what other treatments can't get is a long-sought goal, says Quinones-Hinojosa, who cautions that years of additional studies are needed before human trials of fat-derived MSC therapies could begin.
Quinones-Hinojosa, who treats brain cancer patients at Johns Hopkins Kimmel Cancer Center, says his team was heartened by the fact that the stem cells let loose into the brain in his experiments did not transform themselves into new tumors.
The latest findings build on research published in March 2013 by Quinones-Hinojosa and his team in the journal PLOS ONE, which showed that harvesting MSCs from fat was much less invasive and less expensive than getting them from bone marrow, a more commonly studied method.
Ideally, he says, if MSCs work, a patient with a glioblastoma would have some adipose tissue (fat) removed from any number of locations in the body a short time before surgery. The MSCs in the fat would be drawn out and manipulated in the lab to secrete BMP4. Then, after surgeons removed the brain tumor, they could deposit these treatment-armed cells into the brain in the hopes that they would seek out and destroy the cancer cells.
INFORMATION:
This research was supported by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (RO1NS070024) and the Maryland Stem Cell Research Fund.
Other Johns Hopkins researchers involved in the study include Qian Li, Ph.D.; Olindi Wijesekera; Joanna Y. Wang; Mingxin Zhu, M.D.; Colette ap Rhys, Ph.D.; Kaisorn L. Chaichana, M.D.; David A. Chesler, M.D., Ph.D.; Hao Zhang, M.D.; Christopher L. Smith, Ph.D.; and Hugo Guerrero-Cazares, M.D., Ph.D. Researchers from Yale University also contributed to this work.
For more information:
http://www.hopkinsmedicine.org/news/media/releases/using_fat_to_fight_brain_cancer
Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 30 primary health care outpatient sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report.
Human fat: A trojan horse to fight brain cancer?
Johns Hopkins researchers use stem cells derived from human body fat to deliver treatment for deadly glioblastoma in mice
2014-05-01
ELSE PRESS RELEASES FROM THIS DATE:
Crocodile tears please thirsty butterflies and bees
2014-05-01
The butterfly (Dryas iulia) and the bee (Centris sp.) were most likely seeking scarce minerals and an extra boost of protein. On a beautiful December day in 2013, they found the precious nutrients in the tears of a spectacled caiman (Caiman crocodilus), relaxing on the banks of the Río Puerto Viejo in northeastern Costa Rica.
A boat carrying students, photographers, and aquatic ecologist Carlos de la Rosa was passing slowing and quietly by, and caught the moment on film. They watched [and photographed] in barely suppressed excitement for a quarter of an hour while the ...
Competition of the multiple Gortler modes in hypersonic boundary layer flows
2014-05-01
The present study illustrates, for the hypersonic flows, through the local and marching analysis, the crossover of the mode W and the mode T at O(1) wavenumber and large Görtler number regime. In fact, it is at this wavenumber regime that the instability is most likely to occur. The two approaches are expected to deliver similar results and the marching analysis helps to express the details of the crossover and confirm the result of the local analysis.
In fact the study of Görtler instability goes back to the date of the 1940s. Since Görtler's pioneering investigation ...
Vitamin D deficiency linked to aggressive prostate cancer
2014-05-01
CHICAGO --- African-American and European-American men at high risk of prostate cancer have greater odds of being diagnosed with an aggressive form of the disease if they have a vitamin D deficiency, according to a new study from Northwestern Medicine® and the University of Illinois at Chicago (UIC).
Results of the study will be published May 1 in Clinical Cancer Research, a journal of the American Association for Cancer Research.
"Vitamin D deficiency could be a biomarker of advanced prostate tumor progression in large segments of the general population," said Adam ...
Extreme sleep durations may affect brain health in later life
2014-05-01
BOSTON, MA – A new research study led by Brigham and Women's Hospital (BWH) published in The Journal of the American Geriatrics Society in May, shows an association between midlife and later life sleeping habits with memory; and links extreme sleep durations to worse memory in later life. The study suggests that extreme changes in sleep duration from middle age to older age may also worsen memory function.
"Sleep Duration In Midlife and Later Life In Relation to Cognition: The Nurses' Health Study," led by Elizabeth Devore, ScD, instructor in medicine in the Channing ...
New UT Arlington research could improve pharmaceuticals testing
2014-05-01
A UT Arlington chemistry professor, renowned for his work in the area of chemical separations, is leading an effort to find a more accurate way to measure water content in pharmaceuticals – a major quality issue for drug manufacturers.
Daniel W. Armstrong, UT Arlington's Robert A. Welch Chair in Chemistry, says the new technique could be 100 times more sensitive than one of the most popular current methods.
"The analysis for water in many consumer products, including drugs, is one of the most required tests done in the world," said Armstrong. "Current methods have many ...
Playing pool with carbon atoms
2014-04-30
A University of Arizona-led team of physicists has discovered how to change the crystal structure of graphene, more commonly known as pencil lead, with an electric field, an important step toward the possible use of graphene in microprocessors that would be smaller and faster than current, silicon-based technology.
Graphene consists of extremely thin sheets of graphite: when writing with a pencil, graphene sheets slough off the pencil's graphite core and stick to the page. If placed under a high-powered electron microscope, graphene reveals its sheet-like structure ...
Ground breaking technique offers DNA 'Sat Nav' direct to your ancestor's home 1,000 years ago
2014-04-30
Tracing where your DNA was formed over 1,000 years ago is now possible due to a revolutionary technique developed by a team of international scientists led by experts from the University of Sheffield.
The ground breaking Geographic Population Structure (GPS) tool, created by Dr Eran Elhaik from the University of Sheffield's Department of Animal and Plant Sciences and Dr Tatiana Tatarinova from the University of Southern California, works similarly to a satellite navigation system as it helps you to find your way home, but not the one you currently live in – but rather ...
Cutting cancer to pieces: New research on bleomycin
2014-04-30
A variety of cancers are treated with the anti-tumor agent bleomycin, though its disease-fighting properties remain poorly understood.
In a new study, lead author Basab Roy—a researcher at Arizona State University's Biodesign Institute—describes bleomycin's ability to cut through double-stranded DNA in cancerous cells, like a pair of scissors. Such DNA cleavage often leads to cell death in particular types of cancer cells.
The paper is co-authored by professor Sidney Hecht, director of Biodesign's Center for BioEnergetics. The study presents, for the first time, alternative ...
Infertile women want more support
2014-04-30
VIDEO:
University of Iowa Communication Studies researchers Keli Steuber and Andrew High talk about infertility.
Click here for more information.
Many women coping with infertility count on relatives or close friends for encouragement and assistance. But according to research at the University of Iowa, when it comes to support, women may not be receiving enough—or even the right kind.
"Infertility is a more prevalent issue than people realize. It affects one in six couples, ...
Stem cells from teeth can make brain-like cells
2014-04-30
University of Adelaide researchers have discovered that stem cells taken from teeth can grow to resemble brain cells, suggesting they could one day be used in the brain as a therapy for stroke.
In the University's Centre for Stem Cell Research, laboratory studies have shown that stem cells from teeth can develop and form complex networks of brain-like cells. Although these cells haven't developed into fully fledged neurons, researchers believe it's just a matter of time and the right conditions for it to happen.
"Stem cells from teeth have great potential to grow into ...
LAST 30 PRESS RELEASES:
Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes
Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease
Five University of Tennessee faculty receive Fulbright Awards
5 advances to protect water sources, availability
OU Scholar awarded Fulbright for Soviet cinema research
Brain might become target of new type 1 diabetes treatments
‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts
Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes
Study reveals hidden drivers of asthma flare-ups in children
Physicists decode mysterious membrane behavior
New insights about brain receptor may pave way for next-gen mental health drugs
Melanoma ‘sat-nav’ discovery could help curb metastasis
When immune commanders misfire: new insights into rheumatoid arthritis inflammation
SFU researchers develop a new tool that brings blender-like lighting control to any photograph
Pups in tow, Yellowstone-area wolves trek long distances to stay near prey
AI breakthrough unlocks 'new' materials to replace lithium-ion batteries
Making molecules make sense: A regional explanation method reveals structure–property relationships
Partisan hostility, not just policy, drives U.S. protests
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025
Young human blood serum factors show potential to rejuvenate skin through bone marrow
Large language models reshape the future of task planning
Narrower coverage of MS drugs tied to higher relapse risk
Researchers harness AI-powered protein design to enhance T-cell based immunotherapies
Smartphone engagement during school hours among US youths
Online reviews of health care facilities
MS may begin far earlier than previously thought
New AI tool learns to read medical images with far less data
Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025
Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025
Reporting guideline for chatbot health advice studies
[Press-News.org] Human fat: A trojan horse to fight brain cancer?Johns Hopkins researchers use stem cells derived from human body fat to deliver treatment for deadly glioblastoma in mice